Medtronic plc — Director's Dealing 2019

Nov 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2019-11-01

Reporting Person: COYLE MICHAEL J (EVP & Group Pres, Cardiac&Vasc)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-01	Ordinary Shares	M	37774	$38.81	Acquired	226036	Direct
2019-11-01	Ordinary Shares	S	37774	$109.50	Disposed	188262	Direct
2019-11-01	Ordinary Shares	M	1202	$41.60	Acquired	189464	Direct
2019-11-01	Ordinary Shares	S	1202	$109.50	Disposed	188262	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-01	Stock Option (Right to Buy)	$38.81	M	37774	Disposed	2022-07-30	Ordinary Shares (37774)	Direct
2019-11-01	Stock Option (Right to Buy)	$41.60	M	1202	Disposed	2022-10-29	Ordinary Shares (1202)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Ordinary Shares	250	Indirect
Ordinary Shares	4104	Indirect

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2: This balance increased by 243 shares due to exempt transactions such as dividend reinvestment.

F3: This option to purchase 75,548 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 75,548 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.

F4: This option to purchase 2,404 New Medtronic ordinary shares for $41.60 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,404 Medtronic common stock shares for $41.60 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.